BioInnovation Institute adds Novozymes’ Venture, BioHalo, and  Visibuilt to Venture Lab program

In Copenhagen, nonprofit incubator and life science research institute has added three companies developing biobased materials to its Venture Lab program.

In addition to five biotherapeutics companies, the Venture Lab additions include Novozymes’ Venture, which is evaluating scale cell culture media ingredients for the cultivated meat industry; BioHalo, which developing biobased fluorinated polymers and high-performance materials; and Visibuilt, a company developing solutions for road construction that replace fossil ingredients in asphalt and reduces energy consumption during production.

The 12-month Venture Lab program is designed to support start-up companies with business acceleration, scientific, and team development. It also provides a founder-friendly convertible loan of €500,000 and access to labs and offices at the BII in Copenhagen. The early-stage companies also get an exclusive opportunity to apply for €1.3 million in follow-up funding through BII’s Venture House program.